We retrieved data from the CellMiner database, which included drug activity measurements (drug-tolerant persister NCI-60-Average z score) and gene expression profiles (RNA-seq composite expression) for NFE2L2, NQO1, KIF20A, ETV4, SLC7A11, and CDKN2A in HCC cell lines. This evidence concerns the gene NQO1 and hepatocellular carcinoma.